baber/WOPTO huggingface dataset:
Patent NZ-531621-A (NZ)
Title: Oxazolidinone and/or isoxazoline as antibacterial agents
Inventor: GRAVESTOCK MICHAEL BARRY
IPC: A61P31/04
Filed: 2002-09-09
Abstract: Oxazolidinone and isoxazoline compounds of formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof are disclosed, wherein C is for example (D), (E), (F); wherein A and B are independently selected from (i) and (ii); R2a to R3b are independently selected from hydrogen and fluorine; R1a and R1b are independently selected from, for example, hydroxy, -NHC(=W)R4, (a) and (b); wherein W is O or S; R4 is, for example, hydrogen, amino, (1-4C)alkyl; HET-1 is, for example, a C-linked 5-membered heteroaryl ring; HET-2 is, for example, an N-linked 5-membered, fully or partially unsaturated heterocyclic ring. These compounds are useful as antibacterial agents. Processes for the manufacture of these compounds and pharmaceutical compositions containing them are also disclosed.
Patent NZ-531636-A (NZ)
Title: 3-substituted-4-pyrimidone derivatives as tau protein kinase 1 inhibitor
Inventor: UEHARA FUMIAKI
IPC: C07D401/14
Filed: 2002-09-20
Abstract: A pyrimidone derivative of formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1 is disclosed, wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by formula (II), wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl group; R4 represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.
Patent NZ-532528-A (NZ)
Title: Nicotine-containing pharmaceutical composition comprising chocolate as a vehicle
Inventor: LANDH TOMAS
IPC: A61P25/28
Filed: 2002-09-10
Abstract: Disclosed is a nicotine-containing pharmaceutical composition characterized in that it comprises chocolate as a vehicle. Also disclosed are the processes for the manufacture and use of this composition as a medicament for nicotine replacement (NRT), cessation, reduction and temporary abstinence of tobacco, and for the treatment of Alzheimer's disease, Parkinson's disease, ulcerative colitis and/or Tourette's syndrome; and/or weight control therapy.
Patent NZ-535026-A (NZ)
Title: Paper shredding vehicle
Inventor: WATANABE KATSUAKI
IPC: B02C18/00
Filed: 2004-09-01
Abstract: A vehicle with a paper shredder including a driverÆs cab section, a loading platform section and a box-like container mounted on the loading platform defining a closed space. The container is partitioned, in the order in a direction from the front to the back of the vehicle, into a shredding operation chamber where an operator works, a shredder chamber into which papers are introduced for shredding, and a shred storage chamber for compacting and collecting the shreds. The shredder chamber includes a paper introduction port opened to the shredding operation chamber, a shredder arranged below the paper introduction port including two axis shredding screw blades below the paper introduction port, and a conveyance and compaction unit including a screw conveyor for conveying shredded strips to the shred storage chamber.
Patent NZ-535246-A (NZ)
Title: 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
Inventor: BRYANT MARTIN L
IPC: A61K31/513
Filed: 2001-06-15
Abstract: A 3'-substituted-beta-L-nucleoside of formula (I), and a pharmaceutically acceptable salt thereof is disclosed, wherein R1 is hydrogen, straight chained, branched or cyclic alkyl, CO-alkyl, CO-aryl, CO-alkoxyalkyl, CO-aryloxyalkyl, CO-substituted aryl, akylsulfonyl, arylsulfonyl, aralkylsulfonyl, amino acid residue, mono, di, or triphosphate, or a phosphate derivative; R2 is selected from the group consisting of straight chained, branched or cyclic alkyl, CO-alkyl, CO-aryl, CO-substituted aryl, arylsulfonyl, aralkylsulfonyl, mono, di, or triphosphate, or a phosphate derivative; X is O, S, SO2 or CH2; and BASE is a purine or pyrimidine base that may optionally be substituted. Also disclosed is the use of such a compound in the manufacture of a medicament for the treatment or prophylaxis of a hepatitis B virus infection in a host.
Patent NZ-537757-A (NZ)
Title: Inlet piece for a liquid-injected compressor element
Inventor: BLOCK TOM PAUL MARIA
IPC: F04C18/16
Filed: 2003-07-24
Abstract: An inlet piece is disclosed for a liquid-injected compressor element, characterized in that it comprises a sleeve (8) which consists of a casing (11), a bottom wall (12) provided with an opening (13) and a top wall (14) which is entirely tight, a pipe (9) opening on the inside of the sleeve (8) and a partition (10) comprising a span part which spans the opening (13) in the aforesaid bottom wall (12) and which transforms into an inclosing part (16) reaching down to the bottom wall (13), whereby the partition (10) leaves a passage (18) on one side of the opening (13) and the pipe (9) opens in the sleeve (8) between the top wall (14) and the span part (15), such that, because of the partition (10), gas flowing from the opening (13) to the pipe (9) has to make among others a revolving movement.
Patent NZ-543873-A (NZ)
Title: Ribbed formwork panel
Inventor: GOWRIPALAN SUBODHINI
Filed: 2005-12-01
Abstract: A panel (10) that can be used in forming concrete structures is disclosed. The panel has a number of ribs (20, 22, 24, 26, 28, 30), first and second female connectors (32, 42) near the first edge of the panel, and a male connector (44) near the second edge of the panel. The male connector is able to connect to either female connector of an adjacent panel so that the effective width of the connected panels can be selectively adjusted.
Patent NZ-545429-A (NZ)
Title: Payment transaction system and method
Inventor: MEBRUER ROBERT
IPC: G07F7/08
Filed: 2004-08-18
Abstract: A payment transaction system comprises a receiver processor. The receiver processor has an apparatus for receiving payment data from a communication device belonging to a consumer to enable payment to be made for goods or services, an EPOS checkout terminal and a store back office server having a store database connected to the EPOS checkout terminal. The payment transaction system also comprises a retailer processor having a communication transmission processor and a transaction payment database; a first communication link connecting the receiver processor to the retailer processor; a central facility having a payment approval processor and an account transaction payment database; a second communication link and a third communication link. The account transaction database maintains a database of accounts relating to consumers so that the processor can interrogate the database and determine whether a payment is to be approved or declined. The second communication link is for connecting the retailer processor to the central facility so that the payment data can be transmitted from the store back office server to the payment approval processor, and for transmitting a signal back from the central facility to the retailer processor indicating that payment is approved to enable updating of the transaction payment database of the retailer processor. The third communication link is for communicating the central facility with the receiver processor for enabling an indication of the approval of the payment to be transmitted from the central facility to the receiver processor so that the EPOS checkout terminal is provided with an indication that payment is approved to enable a consumer to receive the goods or services relating to the payment.
Patent NZ-546809-A (NZ)
Title: DNA cloning vector plasmids and methods for their use
Inventor: REED THOMAS D
IPC: C12N15/79
Filed: 2004-05-04
Abstract: Provided is a plasmid comprising a polynucleotide sequence, wherein said sequence comprises a first homing endonuclease site and a total of four sets of restriction sites comprising at least two rare restriction sites that are unique within said plasmid, followed by a second homing endonuclease site, wherein elements are arranged sequentially in the 5' to 3' direction of said plasmid. Further provided are similar plasmids with variations in the presence and location of homing endonuclease sites and number of sets of restriction sites. Further provided are compositions comprising sets of said plasmids. These plasmids are useful in assembling multiple transgene components into plasmids.
Patent NZ-548902-A (NZ)
Title: The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
Inventor: HOLMES DAVID GRENVILLE
Filed: 2003-06-02
Abstract: Disclosed is a use of an active ingredient consisting of a compound of formula (IC) in free form or in the form of a pharmaceutically acceptable acid addition salt, for the manufacture of a medicament for modulating hyperlipidemia.
Patent NZ-551190-A (NZ)
Title: Mixing materials in a skip bin with a digger bucket
Inventor: BRADBURY MARK DOUGLAS TYSON
IPC: B28C5/10
Filed: 2006-11-08
Abstract: A mixing system and method includes a suitable mixing bin 1 into which materials to be mixed are loaded and a digger with an attachment such as a bucket 14 that can be dragged through the material in the bin to mix the material within the bin. The trick is to have the bin up to 30% wider than the mixing bucket so that there is a clearance on either side of the bucket so that material is folded throughout the space between the sides of the bin and the sides of the bucket. The bin is provided with wear strips 7 to reduce wear on the bin due to the motion of the bucket as material is mixed in the bin.
Patent NZ-555588-A (NZ)
Title: Shellfish growing process
Inventor: HEARN BRUCE JOHN
Filed: 2007-05-31
Abstract: A shellfish growing process including: (i) forming a hole in the shellfish that passes through one side of the shell, through the flesh of the shellfish and through the other side of the shellfish; (ii) inserting an attachment means into the hole formed in the shellfish such that the attachment means extends into and passes therethrough and that at least a portion of the attachment means extends outwardly from the shellfish; (iii) attaching the shellfish to a shellfish support means wherein the portion of the attachment means is attached to the shellfish support means such that the shellfish is adapted to be supported on the shellfish support means in a spaced relationship to other shellfish similarly attached to the shellfish support means; and (iv) repeating steops (i) to (iii) to attach further shellfish to the shellfish support means.
Patent NZ-566875-A (NZ)
Title: Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmacueticals
Inventor: MATTER HANS
IPC: C07D213/78
Filed: 2006-09-26
Abstract: Disclosed are [1,2,4]-oxadiazol-5-one derivatives as represented by formula (I) in all their stereoisomeric forms, enantiomeric forms, mixtures physiologically acceptable salts and tautomeric forms, wherein R1, R2 and R3 are independently selected from the group consisting of H, halogen, alkyl, alkylene-O-alkylene-H, cycloalkyl, SCH3, CN, and aryl, wherein the alkyl, alkylene and aryl groups are unsubstituted or 1- to 5-fold substituted by F, or R2 and R3 together with the carbon atoms to which they are bonded form a aryl or a heteroaryl ring; B is C(R4) or N; X is O-CH2, S-CH2, -CH2-, CH2-O, CH2-S, O, S, S(O) or S(O)2; Z is a bond, alkylene, alkenylene, alkylidene or alkylene-O-alkyl; one of U and V is N the other is S or O; and wherein the remaining substituents are as defined herein. Also disclosed is a pharmaceutical which comprises one or more compounds as defined above and one or more active substances which have favourable effects on metabolic disturbances or disorders frequently associated therewith. Further disclosed is the use of the compounds as defined above for the preparation of a medicament for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders, disorders in which insulin resistance is involved, diabetes mellitus including the prevention of the squelae associated therewith, dyslipidemias and their squelae and also neurodegenerative disorders of the central and peripheral nervous system.
Patent NZ-570009-A (NZ)
Title: Plants with EPSPS mutation that are resistant or tolerant to the phosphonomethylglycine herbicide family
Inventor: KNUTH MARK E
IPC: C12N15/09
Filed: 2007-01-10
Abstract: Disclosed is a method for producing a non-transgenic, herbicide resistant or tolerant plant comprising introducing into plant cells a recombinagenic oligonucleobase with a targeted mutation in the EPSPS gene to produce plant cells with a mutant EPSPS gene that expresses a EPSPS protein that is mutated at amino acid position Val114 in an Arabidopsis EPSPS protein (AF360224) and optionally further mutated at one or more amino acid positions selected from the group consisting of: Thr179 and Pro183; selecting a plant cell exhibiting improved tolerance to glyphosate as compared to a corresponding wild-type plant cell; and regenerating a non-transgenic herbicide resistant or tolerant plant having a mutated EPSPS gene from said selected plant cell. Also disclosed are the herbicide resistant plants that result from the disclosed method.
Patent NZ-570356-A (NZ)
Title: Method for the preparation of aqueous dispersions of TiO2 in the form of nanoparticles, and dispersions obtainable with this method
Inventor: BALDI GIOVANNI
IPC: B01J35/00
Filed: 2007-01-29
Abstract: Disclosed is a method for the preparation of nanoparticle dispersions of Titanium dioxide in anatase form, wherein a titanium alkoxide is made to react under heat in water in the presence of mineral acids and a non-ionic surfactant, the solution thus obtained is possibly reduced to a small volume if necessary. Also disclosed are nanoparticles dispersions obtained using said method and the use of said dispersions for the preparation of photolytic coatings.
Patent NZ-575285-A (NZ)
Title: Wall mountable wire grid organizer system with removable accessories
Inventor: NEWBOULD PETER JAMES
IPC: A47K1/09
Filed: 2007-09-04
Abstract: Disclosed is a wall mountable organizer rack assembly which includes a support grid structure with a perimeter frame and a plurality of transverse support members connected with the perimeter frame. The assembly also includes at least one support accessory removably connected with the support members and at least one stretch removable adhesive strip positioned to be arranged between the support grid and a wall for securing the rack to the wall.
Patent NZ-575481-A (NZ)
Title: Simultaneous quantification of nucleic acids in diseased cells
Inventor: STUYVER LIEVEN
IPC: C12N15/09
Filed: 2001-10-18
Abstract: A process for assessing the toxicity of a compound, said process comprising: contacting nucleic acids from a host cell line with an amplification reaction mixture comprising a first and a second primer pair, probe, or primer pair and probe that provide detectable signals during a polymerase chain reaction, wherein the first primer pair, probe, or primer pair and probe provides a detectable signal on the occurrence of the transcription of host mitochondrial nucleic acids; and the second primer pair, probe, or primer pair and probe provides a second detectable signal on the occurrence of the transcription of host nuclear nucleic acid; said process further comprising normalizing the first detectable signal to the second detectable signal and comparing the normalized first detectable signal from a host cell line that has been treated with the compound to a similarly normalized first detectable signal from a host cell line that has not been treated with the compound, in order to assess the toxicity of the compound; and wherein the host cell line is not a peripheral blood mononuclear cell. (62) Divided Out of 561342
Patent NZ-575741-A (NZ)
Title: Vinylogous acids derivatives as chymase inhibitors
Inventor: BANNER DAVID
IPC: C07D209/12
Filed: 2007-10-04
Abstract: Disclosed are vinylogous acid derivatives, as defined in the specification. The vinylogous acid derivatives are used as chymase inhibitors and are useful in the treatment of atherothrombosis and asthma.
Patent NZ-579718-A (NZ)
Title: Masonry replica cladding system
Inventor: GLEESON JAMES
IPC: E04F19/06
Filed: 2008-03-07
Abstract: A masonry replica cladding system which includes a plurality of substantially rectangular flat panels, each panel having: first and second major opposing faces; first and second major opposing edges; and a pair of opposing ends. Each flat panel further includes a first recess in its first major face adjacent the first major edge and a second recess in its second major face adjacent the second major edge. When used to form a portion of a wall cladding, the first major edge of a first flat panel is positioned adjacent the second major edge of an adjacent second flat panel. One of the opposing ends of a panel is substantially aligned with the other corresponding opposing end of an adjacent panel to form respective side edges of a substantially rectangular array of flat panels. The first recess in the first major face of each panel includes a first retaining formation adapted to inter-engage a corresponding retaining formation on an innermost edge of the second recess formed on the second major face. In use the retaining formations act to locate and retain each panel in engaging alignment with an adjacent panel.
Patent NZ-582415-A (NZ)
Title: Methods for producing aripiprazole suspension and freeze-dried formulation
Inventor: HIRAOKA SHOGO
IPC: A61K47/38
Filed: 2008-07-30
Abstract: Disclosed herein is a method for producing an aripiprazole suspension comprising the steps of: a) combining bulk aripiprazole and a vehicle to form a primary suspension; b) subjecting the primary suspension to first pulverization to form a secondary suspension; and c) subjecting the secondary suspension to a second pulverization to form a final suspension, where in the first pulverization of step b), the secondary suspension is formed by pulverizing the primary suspension using a high sheer pulverizing machine or a dispersion machine that applies shear force to a material to be processed, and in the second pulverization of step c), the final suspension is formed by pulverizing the secondary suspension using a high-pressure homogenizer.
Patent NZ-587069-A (NZ)
Title: Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of gsk3-beta
Inventor: FAYOL AUDE
IPC: C07D487/04
Filed: 2009-01-27
Abstract: Disclosed are triaza-benzocycloheptene compounds represented by general formula (I) wherein R3 is benzene or naphthalene. Processes for preparing the compounds are also disclosed. Also disclosed is the use of the compounds of formula (I) for treating Alzheimer's disease, Parkinson's disease, tauopathies, vascular dementia; acute stroke, traumatic injuries; cerebrovascular accidents, brain cord trauma, spinal cord trauma; peripheral neuropathies, retinopathies, glaucoma, non-insulin dependent diabetes; obesity; manic depressive illness; schizophrenia; alopecia; cancers; parenchymal renal diseases, muscle atrophy, malaria, Pemphigus vulgaris, bone diseases or diseases caused by abnormal GSK3-beta activity.
Patent NZ-588821-A (NZ)
Title: Concrete floor grating unit with elastic insert elements
Inventor: VAN DER VELDEN GERT
IPC: A01K1/015
Filed: 2009-05-07
Abstract: 588821 Prefabricated stable floor element comprising a supporting element (2) made of concrete as a grid, with a service face (6) situated at the top when in use and a bottom face (7) situated on the bottom side, whereby the service face (6) has one or several recesses or openings (5), characterised in that in at least one of these recesses or openings (5) has been provided an insert element (9) made of rubber or an elastic synthetic material, so that the insert element does not cover the supporting element service face, with both supporting element service faces and the top of the insert element forming a working surface.
Patent NZ-589157-A (NZ)
Title: Detecting electrical anomalies by receiving sensor data with received anomaly detection rules
Inventor: MONTREUIL MICHEL
IPC: G01R19/25
Filed: 2009-04-14
Abstract: 589157 - Electrical anomaly detection A system for real time monitoring of a powered-on electrical network in a facility in order to detect an electrical anomaly while the electrical network is in use includes a sensor data receiver for receiving real time sensor data including at least one measured value measured in real time by at least one sensor installed on a conductor of the electrical network in the facility. A processor includes an anomaly detector for retrieving an anomaly detection rule from an anomaly detection rule database, the rule having an identification of a required input, a formula, and a threshold reference value, for a detection of an anomaly. The processor receives real time sensor data from the sensor data receiver and extracts at least one relevant measured value from the measured value using the identification of the required input and compares the at least one relevant measured value to the threshold reference value according to the formula to determine one of a presence and an absence of the anomaly in the real time sensor data. An event generator is controlled by the processor for retrieving and providing anomaly monitoring data if the anomaly is determined to be present by the processor, the anomaly monitoring data including an indication of a monitoring course of action to be carried out to address the anomaly determined to be present.
Patent NZ-589763-A (NZ)
Title: New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: CASARA PATRICK
IPC: A61P25/18
Filed: 2010-12-07
Abstract: Disclosed are aza-bicyclo-heptyl compounds represented by general formula (I). Examples of the compounds include 4-{ 3-[(1R,5S)-3-azabicyclo[3.2.0]hept-3-yl]propoxy} benzamide and N-(4-{ 3-[(1R,5S)-3-azabicyclo[3.2.0]hept-3-yl]propoxy} phenyl)acetamide. The compounds are used to treat cognitive and psycho-behavioural disorders associated with cerebral ageing, with neurodegenerative diseases or with cranial traumas.
Patent NZ-590747-A (NZ)
Title: Cycloalkylidene and heterocycloalkylidene hdac inhibitor compounds
Inventor: MELVIN LAWRENCE S
IPC: A61K31/427
Filed: 2009-07-28
Abstract: Disclosed is a compound of general Formula (I) having histone deacetylase (HDAC) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound. Examples of compounds of the invention are: 4-(1-(5-acetyl-4-methylthiazol-2-yl)cyclopropyl)-N-hydroxybenzamide N-hydroxy-4-(1-(4-(imidazo[1,2-a]pyridin-3-yl)thiazol-2-yl)cyclopropyl)benzamide N-hydroxy-4-(1-(4-(1-isopropyl-2-methylimidazol-5-yl)thiazol-2-yl)cyclopropyl)benzamide Diseases may be selected from cell proliferative disease, autosomal dominant disorder, genetic related metabolic disorder, fibrosis, autoimmune disease, diabetes, neurological disease, and Alzheimer's disease.
Patent NZ-593172-A (NZ)
Title: 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
Inventor: ZHANG XUQING
IPC: A61K31/506
Filed: 2009-12-09
Abstract: 593172 Disclosed is a 4-azetidinyl-1-heteroaryl-cyclohexanol compound of formula (I) for treating diabetes.